clemastine has been researched along with Alzheimer Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Y; Jiang, X; Li, G; Ma, R; Sun, S; Wang, C; Wang, M; Wu, Y; Yao, Y; Zheng, S; Zhu, J | 1 |
Chen, H; Chen, LH; Chen, M; Chen, R; Huang, W; Li, ZY; Lu, L; Lu, MH; Ma, QH; Sun, YY; Wang, ZT; Xu, DE; Xu, RX; Zhao, XY | 1 |
Ekins, S; Puhl, AC; Urbina, F | 1 |
1 review(s) available for clemastine and Alzheimer Disease
Article | Year |
---|---|
Recent advances in drug repurposing using machine learning.
Topics: Alzheimer Disease; Antineoplastic Agents; Antiviral Agents; Clemastine; Computational Biology; COVID-19 Drug Treatment; Dipyridamole; Drug Repositioning; Humans; Hydroxychloroquine; Lenalidomide; Machine Learning; Neoplasms; Neuroprotective Agents; Piperazines; Piperidines; Protein Kinase Inhibitors | 2021 |
2 other study(ies) available for clemastine and Alzheimer Disease
Article | Year |
---|---|
Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement.
Topics: Alzheimer Disease; Animals; Autophagy; Clemastine; Cognition; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Neuroinflammatory Diseases; tau Proteins; Tauopathies | 2023 |
Clemastine attenuates AD-like pathology in an AD model mouse via enhancing mTOR-mediated autophagy.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autophagy; Clemastine; Dose-Response Relationship, Drug; HeLa Cells; Histamine H1 Antagonists; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Presenilin-1; TOR Serine-Threonine Kinases | 2021 |